Mutations or translocations of the anaplastic lymphoma kinase (ALK) gene have been detected in several types of cancer, including anaplastic large-cell lymphoma, neuroblastoma, myofibroblastic tumor, and NSCLC (Kwak et al., 2010). The gene discussed is ALK; the disease is neuroblastoma.